Journal of Interdisciplinary Genomics

유전의학융합회 (Interdisciplinary Society of Genetic & Genomic Medicine)
권호 표지
DOI QR코드

DOI QR Code

Kleefstra Syndrome: Review of the Literature

  • Rosie Lee (Department of Pediatrics, School of Medicine, Kyungpook National University, Kyungpook National University Hospital) ;
  • Jung Eun Moon (Department of Pediatrics, School of Medicine, Kyungpook National University, Kyungpook National University Hospital)
  • 투고 : 2023.03.01
  • 심사 : 2023.04.11
  • 발행 : 2023.04.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Kleefstra syndrome is caused by chromosome 9q34.3 deletion or heterozygous mutations in the Euchromatin Histone Methyl Transferase 1 (EHMT1) gene. The prevalence is estimated 1:25,000 to 1:35,000. Intellectual disability, distinctive facial features, hypotonia in childhood can be accompanied. The spectrum of Kleefstra syndrome includes behavioral/psychiatric problems, hearing and visual impairments, seizures, congenital heart defects, genitourinary defects, and obesity. Therefore, it is necessary to understand the pathophysiology and various manifestation of Kleefstra syndrome and discussing with a multidisciplinary team will help diagnose and treat Kleefstra syndrome patients.

키워드

과제정보

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

참고문헌

  1. Schimmenti LA, Berry SA, Tuchman M, Hirsch B. Infant with multiple congenital anomalies and deletion (9)(q34.3). Am J Med Genet 1994;51(2):140-2. https://doi.org/10.1002/ajmg.1320510211
  2. Kleefstra T, Smidt M, Banning MJ, Oudakker AR, Van Esch H, de Brouwer AP, et al. Disruption of the gene Euchromatin Histone Methyl Transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome. J Med Genet 2005;42(4):299-306. https://doi.org/10.1136/jmg.2004.028464
  3. Kleefstra T, Brunner HG, Amiel J, Oudakker AR, Nillesen WM, Magee A, et al. Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. Am J Hum Genet 2006;79(2):370-7. https://doi.org/10.1086/505693
  4. Kleefstra T, van Zelst-Stams WA, Nillesen WM, Cormier-Daire V, Houge G, Foulds N, et al. Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype. J Med Genet 2009;46(9):598-606. https://doi.org/10.1136/jmg.2008.062950
  5. McRae JF, Clayton S, Fitzgerald TW, Kaplanis J, Prigmore E, Rajan D, et al. Prevalence and architecture of de novo mutations in developmental disorders. Nature 2017;542(7642):433-8. https://doi.org/10.1038/nature21062
  6. Willemsen MH, Vulto-van Silfhout AT, Nillesen WM, WissinkLindhout WM, van Bokhoven H, Philip N, et al. Update on Kleefstra Syndrome. Mol Syndromol 2012;2(3-5):202-12. https://doi.org/10.1159/000335648
  7. Vermeulen K, de Boer A, Janzing JGE, Koolen DA, Ockeloen CW, Willemsen MH, et al. Adaptive and maladaptive functioning in Kleefstra syndrome compared to other rare genetic disorders with intellectual disabilities. Am J Med Genet A 2017;173(7):1821-30. https://doi.org/10.1002/ajmg.a.38280
  8. Cormier-Daire V, Molinari F, Rio M, Raoul O, de Blois MC, Romana S, et al. Cryptic terminal deletion of chromosome 9q34: a novel cause of syndromic obesity in childhood? J Med Genet 2003;40(4):300-3. https://doi.org/10.1136/jmg.40.4.300
  9. Kleefstra T, de Leeuw N. Kleefstra Syndrome. GeneReviewsⓇ. [Internet]. Seattle: University of Washington (WA); 1993 (updated on 2023 Jan 26). https://www.ncbi.nlm.nih.gov/books/NBK47079/
  10. Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y. A complex with chromatin modifiers that occupies E2F- and Mycresponsive genes in G0 cells. Science 2022;296:1132-6. https://doi.org/10.1126/science.1069861
  11. Cho KS, Song BK, Lee IS. Neurodevelopmental disorders with epigenetic dysregulation and Drosophila. Front Biosci 2019;24(7):1330-49. https://doi.org/10.2741/4782
  12. Lachner M, O'Sullivan RJ, Jenuwein T. An epigenetic road map for histone lysine methylation. J Cell Sci. 2003;116(11):2117-24. https://doi.org/10.1242/jcs.00493
  13. Vermeulen K, Staal WG; Janzing JG, van Bokhoven H, Egger JIM, Kleefstra T. Sleep disturbance as a Precursor of Severe Regression in Kleefstra Syndrome Suggests a Need for Firm and Rapid Pharmacological Treatment. Clinical Neuropharmacology 2017;40(4):185-8. https://doi.org/10.1097/WNF.0000000000000226
  14. Torga AP, Hodax J, Mori M, Schwab J, Quintos JB. Hypogonadotropic Hypogonadism and Kleefstra Syndrome due to a Pathogenic Variant in the EHMT1 Gene: An Underrecognized Association. Case Rep Endocrinol 2018;2018:4283267.
  15. Knight SJ, Regan R, Nicod A, Horsley SW, Kearney L, Homfray T, et al. Subtle chromosomal rearrangements in children with unexplained mental retardation. Lancet 1999;354(9191):1676-81. https://doi.org/10.1016/S0140-6736(99)03070-6
  16. Dawson AJ, Putnam S, Schultz J, Riordan D, Prasad C, Greenberg CR, et al. Cryptic chromosome rearrangements detected by subtelomere assay in patients with mental retardation and dysmorphic features. Clin Genet 2002;62(6):488-94. https://doi.org/10.1111/j.1399-0004.2002.tb02255.x
  17. de Boer A, Vermeulen K, Egger JIM, Janzing JGE, de Leeuw N, Veenstra-Knol HE, et al. EHMT1 mosaicism in apparently unaffected parents is associated with autism spectrum disorder and neurocognitive dysfunction. Mol Autism 2018;9:5.
  18. Rump A, Hildebrand L, Tzschach A, Ullmann R, Schrock E, Mitter D. A mosaic maternal splice donor mutation in the EHMT1 gene leads to aberrant transcripts and to Kleefstra syndrome in the offspring. Eur J Hum Genet 2013;21(8):887-90. https://doi.org/10.1038/ejhg.2012.267
  19. Guterman S, Herve B, Riviere J, Fauvert D, Clement P, Vialard F. First prenatal diagnosis of a 'pure' 9q34.3 deletion (Kleefstra syndrome): a case report and literature review. J Obstet Gynaecol Res 2017;44(3):570-5.  https://doi.org/10.1111/jog.13517